K

Korsana Biosciences

Develops THETA-enabled neurodegenerative therapeutics

Vice President – Chemistry, Manufacturing, and Control

Bioprocess & BiomanufacturingUpdated on Nov 14
Full-timeWaltham, MA, USAIn-person

About the Job

Requirements

  • A Ph.D. in biochemistry, biochemical engineering, or another relevant physical or life sciences discipline, or an MS/BS with equivalent education or experience, is required.
  • At least 15 years of experience in biologics development and manufacturing in the biotech or biopharma industry, including at least 5 years as a CMC head.
  • Hands-on working experience with successful IND, IMPD, BLA, or MAA submissions and approval is required.
  • Demonstrated ability to develop, implement, and execute CMC strategy for biologics.
  • A proven track record of managing contract development and manufacturing organizations in support of biologics technical development and cGMP manufacturing.
  • Proven leadership capability in developing, coaching, leading, and inspiring team members within the CMC function.
  • A strategic, hands-on approach and ability to balance long-term planning with day-to-day execution.
  • Strong attention to detail and problem-solving skills.
  • Ability to distinguish between critical and non-critical priorities.

Responsibilities

  • Develop, implement, and execute CMC strategy for biologics technical development, including drug substance, drug product, combination product, analytical methods, cGMP manufacturing, and product release and stability testing.
  • Provide technical leadership and oversee biologics product development, scale-up, technology transfer, and analytical method development, qualification, and validation with contract development and manufacturing organizations and contract labs.
  • Build, maintain, and evolve the CMC function to align with the growth of the company’s pipeline.
  • Lead selection of contract development and manufacturing organizations and contract labs, contract negotiation, and budget and scope management.
  • In partnership with Quality Assurance, support deviation investigations and implementation of associated corrective and preventive actions.
  • Author and review CMC sections (Module 3 Quality) of global regulatory submissions, including IND, IMPD, BLA, and MAA submissions.
  • Ensure product supply for clinical and preclinical studies.
  • Maintain an understanding of current trends and emerging biologics development and manufacturing technologies to ensure the team remains at the forefront of biologics CMC.
  • Establish and manage objectives, priorities, and budgets for the CMC function.
  • Develop and maintain standard operating procedures, policies, and guidance documents relevant to areas of responsibility.
  • Regularly update executive management on CMC deliverables and timelines.

Desired Qualifications

  • Experience in a fast-paced, high-growth startup environment.

About the Company

Korsana Biosciences

Develops THETA-enabled neurodegenerative therapeutics

Korsana Biosciences develops therapies for neurodegenerative diseases, with a focus on Alzheimer's disease. Its lead candidate KRSA-028 is a monoclonal antibody that targets amyloid beta and uses the THETA platform to shuttle across the blood-brain barrier, increasing brain exposure. THETA combines TfR1-based shuttling and Fc engineering to improve brain delivery and enable subcutaneous administration while aiming to reduce ARIA risks. The company plans to advance THETA-enabled therapies through clinical trials, with safety data expected in 2027 and initial amyloid clearance proof-of-concept by the end of 2027, supported by funding into 2028.

Company size
11-50
Company stage
IPO
Headquarters
Waltham, MA
Founded
2024

Recently Posted Jobs

Explore more opportunities at Korsana Biosciences

See more jobs